In the current Covid situation and being a US company it may get expedited through the trials. Considering how phase 3 of Ryoncil for Covid19 ARDS could be completed and approved for within 6-8 months, where normally a phase 3 would take years, If this is proven safe and it is effective as it is claimed who knows it may be approved for ARDS within a year. And if it is as potent as it is claimed it may be a preferred treatmebt fir ARDS over Ryoncil.
Competition - Citius Novellus License Deal, page-8
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.10 |
Change
-0.025(2.22%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.16 | $1.09 | $4.434M | 3.989M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 327828 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 18310 | 5 |
View Market Depth
| Last trade - 12.43pm 29/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |